DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,204,495 | +0.7% | 69,345 | -2.6% | 3.73% | +7.1% |
| Q2 2023 | $17,078,880 | +1.5% | 71,162 | +6.6% | 3.48% | -4.2% |
| Q1 2023 | $16,830,475 | -4.7% | 66,777 | +0.4% | 3.63% | -8.6% |
| Q4 2022 | $17,656,535 | +2.7% | 66,523 | -0.0% | 3.98% | -6.8% |
| Q3 2022 | $17,190,000 | +0.8% | 66,555 | -1.0% | 4.26% | +11.6% |
| Q2 2022 | $17,050,000 | -13.5% | 67,255 | +0.1% | 3.82% | -0.5% |
| Q1 2022 | $19,700,000 | -13.8% | 67,159 | -3.3% | 3.84% | -26.0% |
| Q4 2021 | $22,851,000 | +5.3% | 69,455 | -2.6% | 5.19% | -4.1% |
| Q3 2021 | $21,709,000 | +12.4% | 71,309 | -0.9% | 5.41% | +13.3% |
| Q2 2021 | $19,315,000 | +18.1% | 71,975 | -0.9% | 4.78% | +10.0% |
| Q1 2021 | $16,354,000 | +0.1% | 72,660 | -1.2% | 4.34% | -5.4% |
| Q4 2020 | $16,332,000 | +1.2% | 73,519 | -1.9% | 4.59% | -8.4% |
| Q3 2020 | $16,144,000 | +21.4% | 74,974 | -0.3% | 5.01% | +9.2% |
| Q2 2020 | $13,293,000 | +23.0% | 75,173 | -3.7% | 4.59% | +7.7% |
| Q1 2020 | $10,810,000 | -10.8% | 78,098 | -1.1% | 4.26% | +9.8% |
| Q4 2019 | $12,122,000 | +5.2% | 78,982 | -1.0% | 3.88% | -2.9% |
| Q3 2019 | $11,523,000 | +0.1% | 79,786 | -0.9% | 3.99% | -2.8% |
| Q2 2019 | $11,512,000 | +3.8% | 80,550 | -4.1% | 4.11% | +1.6% |
| Q1 2019 | $11,088,000 | +27.5% | 83,986 | -0.4% | 4.04% | +11.4% |
| Q4 2018 | $8,697,000 | -6.0% | 84,341 | -1.0% | 3.63% | +7.5% |
| Q3 2018 | $9,253,000 | +11.5% | 85,156 | +1.3% | 3.37% | +2.6% |
| Q2 2018 | $8,299,000 | +0.9% | 84,096 | +0.1% | 3.29% | -1.3% |
| Q1 2018 | $8,227,000 | +6.2% | 84,028 | +0.7% | 3.33% | +8.6% |
| Q4 2017 | $7,748,000 | +7.7% | 83,478 | -0.4% | 3.07% | +1.3% |
| Q3 2017 | $7,191,000 | +8.9% | 83,833 | +7.1% | 3.03% | +5.2% |
| Q2 2017 | $6,606,000 | +2.9% | 78,275 | +4.3% | 2.88% | -1.7% |
| Q1 2017 | $6,418,000 | +6.9% | 75,035 | -2.7% | 2.93% | +3.2% |
| Q4 2016 | $6,002,000 | -0.8% | 77,108 | -0.1% | 2.84% | -2.1% |
| Q3 2016 | $6,052,000 | -20.6% | 77,203 | +2.3% | 2.90% | -23.0% |
| Q2 2016 | $7,623,000 | +9.3% | 75,473 | +2.6% | 3.76% | +5.0% |
| Q1 2016 | $6,977,000 | -8.3% | 73,548 | -10.2% | 3.59% | -6.0% |
| Q4 2015 | $7,609,000 | +6.9% | 81,928 | -1.9% | 3.81% | +3.8% |
| Q3 2015 | $7,118,000 | -0.9% | 83,533 | -0.5% | 3.67% | +4.2% |
| Q2 2015 | $7,184,000 | +1.5% | 83,938 | +0.7% | 3.53% | +2.9% |
| Q1 2015 | $7,075,000 | -3.0% | 83,338 | -2.1% | 3.43% | +0.2% |
| Q4 2014 | $7,294,000 | +11.5% | 85,098 | -1.2% | 3.42% | -0.2% |
| Q3 2014 | $6,544,000 | +2.5% | 86,123 | +6.2% | 3.43% | +7.1% |
| Q2 2014 | $6,382,000 | +2.5% | 81,058 | -2.4% | 3.20% | -1.5% |
| Q1 2014 | $6,228,000 | -3.7% | 83,043 | -0.9% | 3.25% | -5.1% |
| Q4 2013 | $6,467,000 | +10.0% | 83,768 | -1.2% | 3.42% | +1.0% |
| Q3 2013 | $5,878,000 | +10.1% | 84,792 | +0.5% | 3.39% | +2.4% |
| Q2 2013 | $5,340,000 | – | 84,357 | – | 3.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |